We are live on ! Find out more
BI

Boulegeris Investments Portfolio holdings

AUM $200M
1-Year Est. Return 7%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+7%
3 Year Est. Return
+39.11%
5 Year Est. Return
10 Year Est. Return
AUM
$136M
AUM Growth
+$10.1M
Cap. Flow
+$5.81M
Cap. Flow %
4.28%
Top 10 Hldgs %
62.09%
Holding
51
New
6
Increased
24
Reduced
15
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 23.5%
2 Real Estate 23.19%
3 Technology 11.57%
4 Consumer Staples 7.58%
5 Financials 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAL icon
26
American Airlines Group
AAL
$11.2B
$1.03M 0.76%
19,435
+7,610
+64% +$386K
EOG icon
27
EOG Resources
EOG
$73B
$964K 0.71%
10,510
PNC icon
28
PNC Financial Services
PNC
$102B
$936K 0.69%
10,035
-495
-5% -$44.7K
JPM icon
29
JPMorgan Chase
JPM
$960B
$853K 0.63%
14,080
+1,130
+9% +$66.9K
OPK icon
30
Opko Health
OPK
$978M
$840K 0.62%
59,245
+6,000
+11% +$78.1K
MRO
31
DELISTED
Marathon Oil Corporation
MRO
$828K 0.61%
31,693
+115
+0.4% +$3.12K
IYW icon
32
iShares US Technology ETF
IYW
$25.2B
$817K 0.6%
31,132
-440
-1% -$11.6K
LMT icon
33
Lockheed Martin
LMT
$134B
$788K 0.58%
3,885
-3,125
-45% -$617K
DHC
34
Diversified Healthcare Trust
DHC
$2.17B
$742K 0.55%
+33,751
New +$754K
SIR
35
DELISTED
SELECT INCOME REIT
SIR
$577K 0.43%
+52,484
New +$579K
BMRN icon
36
BioMarin Pharmaceuticals
BMRN
$11.7B
$498K 0.37%
3,995
+1,495
+60% +$158K
MRTX
37
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$484K 0.36%
16,500
+5,425
+49% +$127K
VTI icon
38
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$417K 0.31%
3,885
+140
+4% +$15K
IHE icon
39
iShares US Pharmaceuticals ETF
IHE
$1.64B
$366K 0.27%
6,369
+906
+17% +$49.6K
BRK.B icon
40
Berkshire Hathaway Class B
BRK.B
$1.11T
$340K 0.25%
2,355
META icon
41
Meta Platforms (Facebook)
META
$1.5T
$315K 0.23%
+3,835
New +$300K
RTX icon
42
RTX Corp
RTX
$296B
$312K 0.23%
4,230
+5
+0.1% +$373
AEM icon
43
Agnico Eagle Mines
AEM
$83.5B
$294K 0.22%
10,525
-405
-4% -$12.5K
GOOG icon
44
Alphabet (Google) Class C
GOOG
$4.62T
$280K 0.21%
10,128
-19,052
-65% -$511K
IYY icon
45
iShares Dow Jones US ETF
IYY
$3.06B
$264K 0.19%
5,038
-270
-5% -$14.1K
BRK.A icon
46
Berkshire Hathaway Class A
BRK.A
$1.11T
$218K 0.16%
1
AERI
47
DELISTED
Aerie Pharmaceuticals
AERI
$218K 0.16%
+6,955
New +$202K
HSIC icon
48
Henry Schein
HSIC
$10.1B
$202K 0.15%
+3,698
New +$203K
ACAD icon
49
Acadia Pharmaceuticals
ACAD
$4.93B
-60,720
Closed -$1.93M
BABA icon
50
Alibaba
BABA
$310B
-2,025
Closed -$210K

Similar funds

Boulegeris Investments's Q1 2015 Portfolio in Review

As of Q1 2015, Boulegeris Investments held 51 positions worth $136M, up 8% from $126M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Boulegeris Investments deployed $5.81M of net new capital in Q1 2015, opening 6 new positions and adding to 24 existing holdings. Its largest new stake was Allergan plc: 13,886 shares worth $4.13M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.02M trimmed.

  • Boulegeris Investments's largest Q1 2015 buy was Allergan plc: 13,886 shares worth $4.13M.
  • Boulegeris Investments added most to Walt Disney in Q1 2015, an estimated $1.09M increase.
  • Boulegeris Investments's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $1.02M.
  • Boulegeris Investments fully exited Acadia Pharmaceuticals in Q1 2015, selling an estimated $1.93M.
  • Boulegeris Investments's ten largest holdings make up 62% of its $136M portfolio in Q1 2015.
  • Boulegeris Investments opened 6 new positions and closed 3 in Q1 2015.
  • Boulegeris Investments's portfolio value rose 8% quarter-over-quarter to $136M.

Based on Boulegeris Investments's 13F filing for Q1 2015, filed 12 May 2015.